Table 1 Clinicopathologic characteristics of colorectal cancer patients
From: miR-612 negatively regulates colorectal cancer growth and metastasis by targeting AKT2
Clinical parameters | N (%) |
|---|---|
Sex | |
Male | 25 (62.5%) |
Female | 15 (37.5%) |
Age (years) | |
≤60 | 14 (35.0%) |
>60 | 26 (65.0%) |
Location | |
Ascending colon | 3 (7.5%) |
Transverse colon | 5 (12.5%) |
Descending colon | 10 (25.0%) |
Sigmoid colon | 19 (47.5%) |
Rectum | 3 (7.5%) |
TNM stage | |
I | 5 (12.5%) |
II | 14 (35.0%) |
III | 11 (27.5%) |
IV | 10 (25.0%) |
Histologic differentiation | |
Well | 9 (22.5%) |
Moderately | 17 (42.5%) |
Poorly | 14 (35.0%) |
Lymphatic metastasis | |
Yes | 19 (47.5%) |
No | 21 (52.5%) |
Distant metastasis | |
Yes | 16 (40.0%) |
No | 24 (60.0%) |
